Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shang Zhen Zhou"'
Publikováno v:
Advanced Materials Research. :16-20
Four flavonoid glycosides were isolated from the pulps of Elaeagnus angustifolia and identified as Quercetin 3,4'-O-β-D-diglucoside (1), Isorhamnetin-3-O-β-D-galactopy-ranoside (2), Quercetin 3-O-β-D-Galactopyranoside-4'-O-β-D-glucopyranoside (3)
Autor:
Pete Smith, Michael A. Lochrie, Peter Colosi, Kris Jones, Gwen Tatsuno, Alejandra E. Arbetman, Shang Zhen Zhou, Cheryl Pater, Michiko Kachi, Glenn F. Pierce, Jennifer Wellman McDonnell, Peter A. Campochiaro, Shu Kachi
Publikováno v:
Virology. 353:68-82
Using polymerase chain reactions and genome walking strategies, adeno-associated virus (AAV)-like capsid genes were isolated from rat and mouse liver genomic DNA, where they are present at
Lack of Site-Specific Integration of the Recombinant Adeno-Associated Virus 2 Genomes in Human Cells
Autor:
Dana Erikson, Xu-Shan Wang, Arun Srtvastava, Shang Zhen Zhou, Selvarangan Ponnazhagan, Piruz Nahreini, William G. Kearns
Publikováno v:
Human Gene Therapy. 8:275-284
The adeno-associated virus 2 (AAV)-based vector system has been suggested for its potential use in human gene therapy because the wild-type (wt) AAV genome appears to integrate into the human chromosomal DNA in a site-specific manner. We systematical
Autor:
Shang Zhen Zhou, Mervin C. Yoder, Pinku Mukherjee, Selvarangan Ponnazhagan, Arun Srivastava, Xu-Shan Wang, Samuel C. Wadsworth, Johanne Kaplan
Publikováno v:
Gene. 190:203-210
Adeno-associated virus 2 (AAV), a non-pathogenic human parvovirus, is gaining attention as a vector for its potential use in human gene therapy. However, few studies have examined the safety and the efficacy of this vector system in vivo. We report h
Autor:
Shang Zhen Zhou, Hal E. Broxmeyer, Shelly Heimfeld, Arun Srivastava, Li Ya Kang, L. Ruggieri, Scott Cooper
Publikováno v:
The Journal of Experimental Medicine
Recombinant adeno-associated virus 2 (AAV) virions were constructed containing a gene for resistance to neomycin (neoR), under the control of either the herpesvirus thymidine kinase (TK) gene promoter (vTK-Neo), or the human parvovirus B19 p6 promote
Publikováno v:
Gene. 124:257-262
We have constructed several plasmid vectors with which a more efficient molecular cloning, followed by rescue, replication, and packaging of DNA fragments, can be achieved. The availability of these vectors should facilitate construction of a variety
Autor:
Xu-Shan Wang, Madhavi L. Nallari, Selvarangan Ponnazhagan, Nikhil C. Munshi, Li Ya Kang, Feng Luo, Arun Srivastava, Shang Zhen Zhou, Michael J. Woody
Publikováno v:
The Journal of general virology. 77
Expression from the human parvovirus B19p6 promoter fused to the firefly luciferase (‘Luc’) reporter gene was evaluated in a non-erythroid human nasopharyngeal carcinoma cell line, KB, and a human megakaryocytic leukaemia cell line, MB-02, known
Publikováno v:
Adeno-Associated Virus (AAV) Vectors in Gene Therapy ISBN: 9783642802096
Parvoviruses are among the smallest of the DNA-containing viruses that infect a wide variety of vertebrates (Siegl et al. 1985). Two parvoviruses of human origin, the nonpathogenic adeno-associated virus 2 (AAV) and the parvovirus B19, a common human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe97480367f1c2f450548aea6cf51bf
https://doi.org/10.1007/978-3-642-80207-2_7
https://doi.org/10.1007/978-3-642-80207-2_7
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 92(26)
The pathogenic human parvovirus B19 is an autonomously replicating virus with a remarkable tropism for human erythroid progenitor cells. Although the target cell specificity for B19 infection has been suggested to be mediated by the erythrocyte P-ant
The pathogenic human parvovirus B19 has been shown to undergo productive replication in the erythroid lineage in primary normal human hematopoietic progenitor cells. However, none of the established erythroleukemia cell lines has allowed B19 virus re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f876e3ed89d0719c2d21dafbfb48313
https://europepmc.org/articles/PMC237395/
https://europepmc.org/articles/PMC237395/